ORIC in the 13F filings
Oric Pharmaceuticals Inc · CUSIP 68622P109
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 7 Aug 2026
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 2 listed it in both
- Shares listed
- 22,530,439
- combined, among listed positions
- Reported value
- $244m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,677,979.
Managers listing ORIC in Q2 2026
20 of 20 holders
Largest increases and reductions, by shares
Increases
- D. E. Shaw & Co.existing position · 1,580,216 shares now+1,535,826
- T. Rowe Price Associates Incexisting position · 6,617,554 shares now+1,229,771
- Millennium Management LLCexisting position · 697,694 shares now+663,682
- Two Sigma Investments LPnew position · 603,664 shares now+603,664
- Squarepoint Ops LLCnew position · 344,343 shares now+344,343
Reductions
- Viking Global Investors LPexisting position · 5,126,762 shares now-697,771
- Balyasny Asset Management LLCexisting position · 24,201 shares now-499,589
- Invesco Ltdexisting position · 107,773 shares now-1,181
New positions and exits
New (4)
Exited (5)
- ExodusPoint Capital Management LPwas $2.4m
- Moore Capital Management LPwas $755k
- Jane Street Group LLCwas $672k
- Hudson Bay Capital Management LPwas $157k
- Acadian Asset Management LLCwas $33k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2021 | 1 | $31m | n.a. | n.a. |
| Q2 2021 | 1 | $17m | n.a. | n.a. |
| Q1 2024 | 1 | $55m | 1 | 0 |
| Q2 2024 | 1 | $28m | 0 | 0 |
| Q3 2024 | 1 | $41m | 0 | 0 |
| Q4 2024 | 2 | $42m | 2 | 0 |
| Q1 2025 | 1 | $37m | 1 | 0 |
| Q2 2025 | 2 | $96m | 1 | 0 |
| Q3 2025 | 2 | $110m | 0 | 1 |
| Q4 2025 | 1 | $54m | 14 | 5 |
| Q1 2026 | 3 | $90m | 9 | 15 |
| Q2 2026 | 2 | $69m | 14 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ORIC and LLY →ORIC and JNJ →ORIC and VRTX →Choose a stock to compare with ORIC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ORIC, latest filings →Back to the 13F Explorer →